MiR ‐192/ NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF‐κB pathway-Reference-Cited by-同舟云学术

MiR ‐192/ NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF‐κB pathway

Published:2021-12-24 Issue:3 Volume:13 Page:430-441
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Li Yang¹,Zu Lingling¹^ORCID,Wu Heng¹,Zhang Fang¹,Fan Yaguang¹^ORCID,Pan Hongli¹,Du Xinxin¹,Guo Fengjie¹,Zhou Qinghua¹²

Affiliation:

1. Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital Tianjin China

2. Sichuan Lung Cancer Institute Sichuan Lung Cancer Center, West China Hospital, Chengdu, Sichuan University China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14278

Reference36 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Lung Cancer Statistics

3. New insights into the roles and regulation of SphK2 as a therapeutic target in cancer chemoresistance;Hasanifard L;J Cell Physiol,2018

4. MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma

5. Reduced miR-31 and let-7 maintain the balance between differentiation and quiescence in lung cancer stem-like side population cells

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer and the cell cycle: Focusing on the role of microRNAs;Gene;2024-11

2. NIFK as a potential prognostic biomarker in colorectal cancer correlating with immune infiltrates;Medicine;2023-10-06

3. Nanotechnology-empowered lung cancer therapy: From EMT role in cancer metastasis to application of nanoengineered structures for modulating growth and metastasis;Environmental Research;2023-09

4. Roles of microRNA-192 in diabetic nephropathy: the clinical applications and mechanisms of action;Frontiers in Endocrinology;2023-06-15

5. Modulating multidrug resistance to drug-based antitumor therapies through NF-κB signaling pathway: mechanisms and perspectives;Expert Opinion on Therapeutic Targets;2023-06-03